Data / Form D filings / ADURO BIOTECH, INC.
ADURO BIOTECH, INC.: Form D filings
ADURO BIOTECH, INC., a biotechnology company in Berkeley, CA, filed 9 Form D notices with the SEC between 2009 and 2015. The latest, on January 5, 2015, reports $51.4 million sold of a $51.4 million offering to 28 investors.
Find out what ADURO BIOTECH, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 626 BANCROFT WAY, SUITE 3-C, Berkeley, CA, 94710
- Phone
- (510) 848-4400
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2011
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1435049
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 5, 2015 | New notice | $51,388,002 | $51,388,002 | $0 | 28 | Dec 19, 2014 | sec.gov |
| Jun 13, 2014 | New notice | $40,602,333 | $40,602,333 | $0 | 25 | May 30, 2014 | sec.gov |
| Sep 10, 2013 | New notice | $13,000,000 | $7,000,000 | $6,000,000 | 1 | Aug 12, 2013 | sec.gov |
| Feb 12, 2013 | Amendment | $25,729,450 | $25,573,536 | $155,914 | 11 | Apr 15, 2011 | sec.gov |
| Dec 5, 2011 | New notice | $512,100 | $512,100 | $0 | 1 | Oct 24, 2011 | sec.gov |
| Apr 22, 2011 | New notice | $19,233,346 | $2,228,674 | $17,004,672 | 9 | Apr 15, 2011 | sec.gov |
| Apr 9, 2010 | New notice | $768,847 | $768,847 | $0 | 14 | Mar 5, 2010 | sec.gov |
| Nov 17, 2009 | New notice | Indefinite | $1,175,000 | Indefinite | 9 | Nov 3, 2009 | sec.gov |
| Nov 17, 2009 | New notice | $1,775,000 | $1,775,000 | $0 | 13 | Dec 2, 2008 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Frank McCormick | Director | |
| Gerald David Chan | Director | |
| Thomas W. Dubensky | Executive Officer | |
| Dirk G. Brockstedt | Executive Officer | |
| Ross Haghighat | Director | |
| William Greenman | Director | |
| Stephanie O'Brien | Director | |
| Stephen Isaacs | Executive Officer, Director | |
| Jennifer W. Lew | Executive Officer | |
| Gregory W. Schafer | Executive Officer |
Other biotechnology companies in California that filed recently
- CARI Health, Inc. $280,000 · Nov 6, 2026
- Ausel, Inc. $120,000 · Nov 4, 2026
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
- Tempest Therapeutics, Inc. $7.5 million · Oct 14, 2026
- Lionheart Health, Inc. $387,500 · Oct 7, 2026
- Rakuten Medical, Inc. $9 million · Oct 6, 2026
- Zonaliz, Inc. $2.5 million · Oct 5, 2026
- Altay Therapeutics, Inc. $15.7 million · Oct 2, 2026
- Sialia Therapeutics, Inc. $1.5 million · Sep 29, 2026
- Vetmab Biosciences, Inc. $11.4 million · Sep 29, 2026
Every Form D from the week of Jan 5, 2015 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what ADURO BIOTECH, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.